A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study

被引:0
|
作者
Rudolph M. Navari
Lawrence H. Einhorn
Patrick J. Loehrer
Steven D. Passik
Jake Vinson
John McClean
Naveed Chowhan
Nasser H. Hanna
Cynthia S. Johnson
机构
[1] University of Notre Dame,Notre Dame Cancer Institute
[2] Indiana University School of Medicine South Bend,Division of Hematology
[3] Indiana University Medical Center,Oncology
[4] Indiana University Cancer Center,Division of Biostatistics
[5] Memorial Sloan-Kettering Cancer Center,undefined
[6] Hoosier Oncology Group,undefined
[7] Medical and Surgical Specialists,undefined
[8] Cancer Care Center,undefined
[9] Indiana University School of Medicine,undefined
来源
Supportive Care in Cancer | 2007年 / 15卷
关键词
Olanzapine; Palonosetron; Dexamethasone; Chemotherapy; Anti-emetic therapy; Delayed emesis;
D O I
暂无
中图分类号
学科分类号
摘要
引用
收藏
相关论文
共 50 条
  • [1] A phase II trial of olanzapine, dexamethasone, and palonosetron for the prevention of chemotherapy-induced nausea and vomiting: a Hoosier oncology group study
    Navari, Rudolph M.
    Einhorn, Lawrence H.
    Loehrer, Patrick J., Sr.
    Passik, Steven D.
    Vinson, Jake
    McClean, John
    Chowhan, Naveed
    Hanna, Nasser H.
    Johnson, Cynthia S.
    SUPPORTIVE CARE IN CANCER, 2007, 15 (11) : 1285 - 1291
  • [2] A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A Hoosier Oncology Group study
    Rudolph M. Navari
    Lawrence H. Einhorn
    Steven D. Passik
    Patrick J. Loehrer
    Cynthia Johnson
    M. L. Mayer
    J. McClean
    Jake Vinson
    W. Pletcher
    Supportive Care in Cancer, 2005, 13 : 529 - 534
  • [3] A phase II trial of olanzapine for the prevention of chemotherapy-induced nausea and vomiting: A Hoosier Oncology Group study
    Navari, RM
    Einhorn, LH
    Passik, SD
    Loehrer, PJ
    Johnson, C
    Mayer, ML
    McClean, J
    Vinson, J
    Pletcher, W
    SUPPORTIVE CARE IN CANCER, 2005, 13 (07) : 529 - 534
  • [4] A phase II trial of olanzapine and palonosetron for the prevention of chemotherapy induced nausea and vomiting (CINV).
    Navari, R. M.
    Einhorn, L. H.
    Loehrer, P. J.
    Passik, S. D.
    Vinson, J.
    McClean, J.
    Chowhan, N.
    Hanna, N.
    Calley, C.
    Yu, M.
    JOURNAL OF CLINICAL ONCOLOGY, 2006, 24 (18) : 495S - 495S
  • [5] A Phase II study of palonosetron, aprepitant, dexamethasone and olanzapine for the prevention of cisplatin-based chemotherapy-induced nausea and vomiting in patients with thoracic malignancy
    Nakashima, Kazuhisa
    Murakami, Haruyasu
    Yokoyama, Kouichi
    Omori, Shota
    Wakuda, Kazushige
    Ono, Akira
    Kenmotsu, Hirotsugu
    Naito, Tateaki
    Nishiyama, Fumie
    Kikugawa, Mami
    Kaneko, Masayo
    Iwamoto, Yumiko
    Koizumi, Satomi
    Mori, Keita
    Isobe, Takeshi
    Takahashi, Toshiaki
    JAPANESE JOURNAL OF CLINICAL ONCOLOGY, 2017, 47 (09) : 840 - 843
  • [7] Palonosetron for the prevention of chemotherapy-induced nausea and vomiting
    Mori-Vogt, Sherry
    Blazer, Marlo
    EXPERT REVIEW OF ANTICANCER THERAPY, 2013, 13 (08) : 919 - 936
  • [8] Olanzapine for the Prevention of Chemotherapy-Induced Nausea and Vomiting
    Navari, Rudolph M.
    Qin, Rui
    Ruddy, Kathryn J.
    Liu, Heshan
    Powell, Steven F.
    Bajaj, Madhuri
    Dietrich, Leah
    Biggs, David
    Lafky, Jacqueline M.
    Loprinzi, Charles L.
    NEW ENGLAND JOURNAL OF MEDICINE, 2016, 375 (02): : 134 - 142
  • [9] Palonosetron and netupitant for prevention of chemotherapy-induced nausea and vomiting
    De Lartigue, Jane
    JOURNAL OF COMMUNITY AND SUPPORTIVE ONCOLOGY, 2015, 13 (04): : 128 - 130
  • [10] Palonosetron hydrochloride for the prevention of chemotherapy-induced nausea and vomiting
    Ruhlmann, Christina
    Herrstedt, Jorn
    EXPERT REVIEW OF ANTICANCER THERAPY, 2010, 10 (02) : 137 - 148